phar (Molecular target)
問題一覧
1
Na+/K+ ATPase inhibitor
2
blocks muscarinic AChR
3
inhibits RNA polymerase
4
activates Ga5 proteins
5
inhibits Ga i/o proteins
6
inhibits synaptic protein
7
block k+ channels
8
block Ca2+ channels
9
blocks Na+ channels
10
Na+/K+ ATPase inhibitor
11
Hepatotoxicity, Nephrotoxicity, GI toxicity, Teeth discoloration, Retardation of bone growth, Cardiotoxicity
12
Receptors, Organ-directed toxicity, Mutagenesis and carcinogenesis, Teratogenicity, Biochemical pathway toxins, Allergic response
13
Chemical synthesis (Aspirin)
14
Nonsteroidal anti-inflammatory drug
15
Human insulin production
16
Active pharmaceutical ingredient, Excipient
17
Physico-chemical properties of drug, Dosage form, Excipients, Site of absorption of the administered drug, Co-administration of other drugs, Types of food taken by the patients, Age and genetic composition of the patient, Disease state of the patient may affect ADME profile of drugs
18
Prescription of drugs, Non-prescription drugs, Recreational drugs, Food supplements
19
Natural, Synthetic, Biosynthetic
20
Plant (Opioid), Animal (Heparin), Microorganisms (Antibiotics), Inorganic compounds (Zinc oxide)
21
Diagnosis of diseases, Prevention of diseases, Control or cure of diseases
22
smaller than 500 KDa
23
Covalent bond, Hydrophobic interaction, Electrostatic force
24
High-throughput screening
25
Absorption, Distribution, Metabolism, Excretion
26
Oral, Sublingual, Rectal, Inhalation, Topical, Transdermal, Subcutaneous, Intravenous, Intramuscular
27
The blood flow to the tissue, Solubility of the drug in the tissue, Binding of drug to macromolecules, The ability to cross special barriers
28
Carbon monoxide, Cyanide
29
Particle size, Chemical nature
30
Oral, Parenteral, Nasal, Pulmonary, Transdermal
31
Phsico-chemical properties of drugs, Body effects and interaction, Improvement of drug effect, Patient comfort and well being
32
losing electron
33
Multidrug resistance protein-1 (MDR1), Multidrug resistance associated protein 1 (MRP1)
34
Lipid soluble
35
Drug, Drug release membrane, Contact adhesive, Backing
36
Taken once daily with food, Only for adults, Fewer side effects such as diarrhea and vomiting
37
Taken twice daily, Treat type II diabetes in both adults and children, Never be crushed or broken
Mechanisms of action of toxins
Mechanisms of action of toxins
Hui Suki · 27問 · 2年前Mechanisms of action of toxins
Mechanisms of action of toxins
27問 • 2年前Chapter 5
Chapter 5
Hui Suki · 6問 · 2年前Chapter 5
Chapter 5
6問 • 2年前do more
do more
Hui Suki · 7問 · 2年前do more
do more
7問 • 2年前Chapter 1
Chapter 1
Hui Suki · 21問 · 2年前Chapter 1
Chapter 1
21問 • 2年前Chapter 3
Chapter 3
Hui Suki · 24問 · 2年前Chapter 3
Chapter 3
24問 • 2年前問題一覧
1
Na+/K+ ATPase inhibitor
2
blocks muscarinic AChR
3
inhibits RNA polymerase
4
activates Ga5 proteins
5
inhibits Ga i/o proteins
6
inhibits synaptic protein
7
block k+ channels
8
block Ca2+ channels
9
blocks Na+ channels
10
Na+/K+ ATPase inhibitor
11
Hepatotoxicity, Nephrotoxicity, GI toxicity, Teeth discoloration, Retardation of bone growth, Cardiotoxicity
12
Receptors, Organ-directed toxicity, Mutagenesis and carcinogenesis, Teratogenicity, Biochemical pathway toxins, Allergic response
13
Chemical synthesis (Aspirin)
14
Nonsteroidal anti-inflammatory drug
15
Human insulin production
16
Active pharmaceutical ingredient, Excipient
17
Physico-chemical properties of drug, Dosage form, Excipients, Site of absorption of the administered drug, Co-administration of other drugs, Types of food taken by the patients, Age and genetic composition of the patient, Disease state of the patient may affect ADME profile of drugs
18
Prescription of drugs, Non-prescription drugs, Recreational drugs, Food supplements
19
Natural, Synthetic, Biosynthetic
20
Plant (Opioid), Animal (Heparin), Microorganisms (Antibiotics), Inorganic compounds (Zinc oxide)
21
Diagnosis of diseases, Prevention of diseases, Control or cure of diseases
22
smaller than 500 KDa
23
Covalent bond, Hydrophobic interaction, Electrostatic force
24
High-throughput screening
25
Absorption, Distribution, Metabolism, Excretion
26
Oral, Sublingual, Rectal, Inhalation, Topical, Transdermal, Subcutaneous, Intravenous, Intramuscular
27
The blood flow to the tissue, Solubility of the drug in the tissue, Binding of drug to macromolecules, The ability to cross special barriers
28
Carbon monoxide, Cyanide
29
Particle size, Chemical nature
30
Oral, Parenteral, Nasal, Pulmonary, Transdermal
31
Phsico-chemical properties of drugs, Body effects and interaction, Improvement of drug effect, Patient comfort and well being
32
losing electron
33
Multidrug resistance protein-1 (MDR1), Multidrug resistance associated protein 1 (MRP1)
34
Lipid soluble
35
Drug, Drug release membrane, Contact adhesive, Backing
36
Taken once daily with food, Only for adults, Fewer side effects such as diarrhea and vomiting
37
Taken twice daily, Treat type II diabetes in both adults and children, Never be crushed or broken